Our Research Training Group
- Motivation
- Publications
-
Projects
- P1: Drug targeting to metastases
- P2: Priming tumor blood vessels and the microenvironment
- P3: Modulating macrophages to improve drug delivery and immunotherapy
- P4: Dual targeting of inflammation to inhibit the initiation and progression of HCC
- P5: Theranostic nanogels with optimal tumor penetration properties
- P6: Auger-emitting theranostics for personalized radiochemotherapy
- P7: Dispersion-based production of multi-drug DDS for HCC chemoimmunotherapy
- P8: Continuous-flow manufacturing of actively targeted DDS
- P9: Sonoporation to improve drug delivery to breast cancer
- P10: Antibody-drug conjugates for monocytic leukemia
- P11: Repurposing of iron oxide nanoparticles for theranostic combination therapies
- P12: Liposomal dexamethasone for multiple myeloma therapy
- Master Thesis